Psychological perspective of medication adherence in transplantation by De Pasquale, Concetta et al.
Concetta De Pasquale, Massimiliano Veroux, Michele Fornaro, Nunzia Sinagra, Giusi Basile, Cecilia Gozzo, 
Roberta Santini, Alessandra Costa, Maria Luisa Pistorio
Concetta De Pasquale, Massimiliano Veroux, Michele Fornaro, 
Nunzia Sinagra, Giusi Basile, Cecilia Gozzo, Roberta Santini, 
Alessandra Costa, Maria Luisa Pistorio, Vascular Surgery and 
Organ Transplant Unit, Department of Medical, Surgery Sciences 
and Advanced Technologies “GF Ingrassia”, University of Catania, 
95123 Catania, Italy
Author contributions: De Pasquale C and Pistorio ML contributed 
to study conception, design, and writing; Sinagra N, Basile G, 
Gozzo C, Santini R and Costa A contributed to data acquisition; 
Fornaro M contributed to data analysis and interpretation; Veroux M 
contributed to editing, reviewing, and final approval of the article.
Institutional review board statement: The study was reviewed 
and approved by the University of Catania Institutional Review 
Board.
Informed consent statement: All study participants, or their 
legal guardian, provided informed written consent prior to study 
enrollment. 
Conflict-of-interest statement: None of the authors declare any 
conflict of interest. 
Data sharing statement: Technical appendix, statistical code, and 
dataset available from the corresponding author at depasqua@unict.
it. Participants gave informed consent for data sharing. 
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Manuscript source: Invited manuscript
Correspondence to: Concetta De Pasquale, MD, PhD, 
Vascular Surgery and Organ Transplant Unit, Department of 
Medical, Surgery Sciences and Advanced Technologies “GF 
Ingrassia,” University of Catania, Via Santa Sofia, 84, 95123 
Catania, Italy. depasqua@unict.it
Telephone: +39-095-3782629 
Fax: +39-095-3782629
Received: June 24, 2016
Peer-review started: June 27, 2016
First decision: August 11, 2016
Revised: September 13, 2016
Accepted: October 25, 2016
Article in press: October 27, 2016
Published online: December 24, 2016
Abstract
AIM
To identify the risk factors and the post-transplant psy-
chological symptoms that affect adherence to therapy in a 
population of kidney transplant recipients. 
METHODS
The study examined the psychological variables likely 
responsible for the non-adherent behavior using a 
psychological-psychiatric assessment, evaluation of the 
perception of patients’ health status, and an interview 
regarding the anti-rejection drug therapy assumption. The 
study included 74 kidney transplant recipients. 
RESULTS
Individuals with a higher level of education and more 
years since transplantation showed better mental balance. 
Regarding gender, women appeared to be less adherent 
to therapy. Further, the years since transplantation 
adversely affected the proper pharmacological assum-
ption. Adherence to therapy did not significantly change 
with the mental health index. 
CONCLUSION
The biopsychosocial illness model provides a conceptual 
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frame of reference in which biological, psychological, 
and social aspects take on the same importance in 
the adherence to treatment protocols. For effective 
management, it is necessary to understand the patients’ 
personal experiences, their assumptions about the 
disease, health status perception, and mood, and to 
identify any “barriers” that could cause them to become 
noncompliant.
Key words: Transplantation; Adherence; Mental health; 
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Core tip: Therapeutic Adherence after transplantation is 
of fundamental importance for the patient’s short- and 
long-term well-being and assumes a set of adaptations 
to a new lifestyle. The authors in this study analyzed the 
psychological characteristics of a sample of transplant 
recipients and different temperament styles, yet not 
studied in other research on transplantation. The results 
suggested that different temperaments influence in 
different ways the treatment compliance and showed 
that the transplant experience change behaviors and 
quality of life based on the personality and temperament 
characteristics. In conclusion, post-transplant psychological 
support positively affects adherence to treatment, and 
coping strategies of the subject.
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IntroductIon
The theme of therapeutic adherence (TA) plays a central 
role in research on education and health promotion[1]. 
Adherence to immunosuppressive therapy after trans­
plantation is of fundamental importance for the patients’ 
well­being both short­ and long­term and assumes a set of 
adaptations to a new lifestyle. The treatment effectiveness 
and transplant success not only depend on the correct 
choice of immunosuppressive drugs, but also on the 
patients’ active participation in the therapeutic program 
that often includes psychological support and appropriate 
motivation[2,3].
Non­adherence to therapy in transplant patients 
is one of the emerging causes of early and late graft 
loss. Patients with an organ transplant must take imm­
unosuppressive drugs daily for the prevention of acute and 
chronic rejection. There is an obvious relationship between 
the discontinuity in the use of immunosuppressive drugs 
and the incidence of transplant failures in the medium and 
long term[4]. Non­adherence to the transplant medication 
regimen can lead to graft rejection, post­transplant 
mortality, increase in healthcare costs, and decrease in 
quality of life[5,6]. One meta­analysis found non­adherence 
to medication across all organ transplants to be 22.6%[7]. 
An estimated 50% of late acute rejections and 15% of 
graft losses are associated with non­adherence[8]. An 
essential aspect to ensure full adherence to the treatment 
is the assessment of transplant recipient needs and his/
her expectations while establishing a good therapeutic 
alliance[9]. Many studies evaluating the relationship 
between the healthcare team and the patient highlighted 
the need for a relationship based on trust and clarity 
for the sharing of information regarding the treatment 
course[10,11]. Even psychological and psychosocial aspects 
can alter the response to treatment[12,13]: Mood disorders, 
high levels of anxiety, hostility, and the presence of 
“unstable” personality traits are associated with an 
increased risk of non­adherence to medical prescriptions in 
kidney transplant recipients[14­16]. 
Adherence to therapy thus is a complex variable 
and influenced by many factors: Socio­demographics, 
psychological characteristics, transplant recipient self­
efficacy, factors related to immunosuppressive therapy, 
and the doctor­patient relationship. The aim of this 
study is to identify the risk factors and post­transplant 
psychological symptoms that affect adherence to therapy 
in a population of kidney transplant recipients. 
MAtErIALS And MEtHodS
The study examined the psychological variables that are 
likely responsible for the non­adherent behavior using a 
psychological­psychiatric assessment, evaluation of the 
perception of patients’ health status, and an interview 
regarding the anti­rejection drug therapy assumption. 
The psychological­psychiatric assessment involved the 
use of the following tests:
The Symptom Checklist­90­Revised (SCL­90­R) 
evaluated psychological symptoms. It is a relatively brief 
self­report psychometric instrument (questionnaire) 
published by the Clinical Assessment division of the 
Pearson Assessment and Information group. It is one 
of the most widely used measures of psychological 
distress in clinical practice and research and is designed 
to evaluate a broad range of psychological problems 
and symptoms of psychopathology. According to the 
overview given by the publisher, the SCL­90­R is normed 
on individuals 13 years and older. It consists of 90 
items and takes 12­15 min to administer. The following 
primary symptom dimensions are assessed: Somatization 
(SOM), obsessive­compulsive (OBS), interpersonal 
sensitivity (INT), depression (DEP), anxiety (ANX), hostility 
(HOS), phobic anxiety (PHOB), paranoid ideation (PAR), 
psychoticism (PSY), and a category of “additional items” 
that helps clinicians assess other aspects of the patient’s 
symptoms[17,18]. A large number of studies have been 
conducted demonstrating the reliability, validity, and 
utility of the instrument[19­22]. 
Personality study has provided an analysis of the 
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temperament variables by the TEMPS­A (Temperament 
Evaluation of Memphis, Pisa and San Diego Autoques­
tionnaire). The features of temperament as well as its 
intensity may exert a constructive or destructive impact 
on the quality of life[23]. The TEMPS­A contains 110 
items (109 in the version for males) measuring affective 
temperament traits occurring throughout life of the 
subject, as represented by five dimensions: Depressive 
(DT), cyclothymic (CT), hyperthymic (HT), irritable (IT), 
and anxious (AT). Questions about the various types are 
grouped together. The TEMPS­A measures the severity 
of the temperament traits ranging from 0 to 1. The 
calculation of points for each temperament is done by 
dividing the sum of points obtained in a given subscale 
by the number of questions contained therein[24,25].
Quality of life was examined with the Short Form 
Health Survey (SF­36) that assesses the degree of 
self­perceived psychological well­being. The SF­36 
consists of eight subscales: Vitality, physical functioning, 
bodily pain, general health perceptions, physical role 
functioning, emotional role functioning, social role 
functioning, and mental health. Subscales are presented 
as scores between 0 and 100; a lower score indicates 
more disability and a higher score less disability. The 
two considered variables in this study were the physical 
index score (PIS) and mental index score (MIS). The 
validity and reliability of the SF-36 has been confirmed 
in patients with renal disease[26,27].
Therapeutic adherence was studied through the 
Basel Assessment of Adherence to Immunosuppressive 
Medication instrument (BAASIS), which was developed 
to assess adherence to immunosuppressive medication 
in adult transplant patients. The instrument measures 
patients’ taking, skipping, timing (± 2 h from the 
prescribed time, TM), and dose reduction of drugs. The 
recall period is limited to four weeks. The BAASIS com­
prises four questions with a 6­point scale for responses 
ranging from never (0) to every day (5). In addition, the 
BAASIS has a visual analogue scale (VAS) ranging from 
0% (medication never taken as prescribed) to 100% 
(medication always taken as prescribed)[28,29]. 
The current study included 74 kidney transplant 
recipients (32 females, 43.25%), with a mean age of 48.3 
± 13.6 years (range 22­75). Demographic data regarding 
years since transplant procedure (first transplantation), 
occupation, level of education are presented in Table 1. All 
patients underwent a standardized immunosuppressive 
protocol with tacrolimus, mycophenolate mofetil, and 
steroids. The basic psychological­psychiatric assessment 
excluded the presence of lifetime psychiatric disorders 
(axis I) according to the Diagnostic and Statistical Manual 
for Mental Disorders (5th ed., DSM­5) or concomitant use 
of drugs that could influence cognitive and emotional 
aspects[30]. All patients provided written informed consent 
after the procedures were fully explained by a trained 
physician (MD, psychiatrist) or a psychologist. 
The data were examined for normality and trans­
formed if necessary. Pearson’s R correlation test was 
performed using the “Statistical Package for Social 
Sciences” (SPSS, Version 17). The P value of less than 
0.05 (P < 0.05) was considered statistically significant. In 
addition, we applied multivariate linear regression analysis 
to predict the outcome variable (BAASIS total score, 
BT) from predictor variables (patterns of personality and 
demographic characteristics). 
rESuLtS
The current study included 74 kidney transplant recipients 
(32 females, 43.25%), with a mean age of 48.3 ± 
13.6 years (range 22­75). Demographic data regarding 
years since transplant procedure (first transplantation), 
occupation, level of education are presented in Table 1. All 
patients underwent a standardized immunosuppressive 
protocol with tacrolimus, mycophenolate mofetil, and 
steroids. Correlations by the Pearson coefficient bet­
ween results of the SCL­90­R, SF­36 (physical and 
mental index score), and demographic characteristics 
of the sample are shown in Figure 1. Individuals with 
a higher level of education (E) and with more years of 
transplantation (YT) showed higher mental balance (E/
MIS r = 0.61; YT/MIS r = 0.48). Specifically, the level 
of education was negatively correlated with anxious, 
obsessive­compulsive, and depression aspects (E/OBS r 
= ­0.81; E/DEP r = ­0.67; E/ANX r = ­0.59). 
Correlations by the Pearson coefficient between results 
of the BAASIS, SF­36 (physical and mental index score), 
and demographic characteristics of the sample are shown 
in Figure 2. Regarding gender, women (female sex, FS) 
appeared to be less adherent to therapy in our study 
(FS/BT r = 0.46), while years of transplantation adversely 
affected the proper pharmacological assumption (YT/BT 
r = 0.34). In addition, as the index of subjective physical 
well­being increases, compliant behavior increases 
as well (PIS/BT r = ­0.47), especially with regards to 
the treatment assumption of correct timing (PIS/TM r 
= ­0.27). Adherence to therapy was not significantly 
correlated with the mental health index (MIS/BT r = 
­0.01). 
Correlations by the Pearson coefficient between the 
results of the TEMPS­A, BAASIS of the sample are shown 
in Figure 3. The temperament variables measured with 
the TEMPS­A were correlated with treatment adherence. 
Specifically, the cyclothymic, irritable, and depression 
personality adversely affected adherent behavior (BT/CT 
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Table 1  Demographic data (n  = 74 kidney transplant responders)
Years since transplantation procedure, mean 
± SD (range)
5.39 ± 3.74 (1.00-14.00)
Education
  Basic 36%
  High school 56%
  University   8%
Occupation
  Employed 31.17%
  Unemployed 56.82%
  Retired 12.01%
De Pasquale C et al . Psychological perspective of medication adherence
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variable (TM/DT r = 0.52), suggesting time management 
difficulties for patients with a depressive personality.
Multivariate linear regression analysis showed high 
r = 0.39; BT/IT r = 0.44; BT/DT r = 0.21); however, a 
moderate positive correlation was found between the 
timing scale of the BAASIS and depressive temperament 
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Figure 1  Correlations between symptom Checklist-90-R, short form health survey, and demographic characteristics. SF-36: Short form health survey; SOM: 
Somatization; OBS: Obsessive-compulsive; INT: Interpersonal sensitivity; DEP: Depression; ANX: Anxiety; HOS: Hostility; PHOB: Phobic anxiety; PAR: Paranoid 
ideation; PSY: Psychoticism; PIS: Physical index score of SF-36; MIS: Mental index score of SF-36; YT: Years since transplant procedure; E: Education; FS: Female 
sex. Correlation coefficients (r) < 0.3 indicate weak correlation, ≤ 0.7 moderate correlation, > 0.7 strong correlation.
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Figure 2  Correlations between basel assessment of adherence to immunosuppressive medication instrument, short form health survey, and demographic 
characteristics. BAASIS: Basel assessment of adherence to immunosuppressive medication instrument; BT: BAASIS total score; TK: BAASIS taking dimension; 
TM: BAASIS timing dimension; SF-36: Short form health survey; PIS: Physical index score of SF-36; MIS: Mental index score of SF-36; E: Education; YT: Years since 
transplant procedure; FS: Female sex. Correlation coefficients (r) < 0.3 indicate weak correlation, ≤ 0.7 moderate correlation, > 0.7 strong correlation.
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Figure 3  Correlations between temperament evaluation of memphis, pisa and san diego autoquestionnaire and basel assessment of adherence 
to immunosuppressive medication instrument. BAASIS: Basel assessment of adherence to immunosuppressive medication instrument; DT: Depressive 
temperament; CT: Cyclothymic temperament; HT: Hyperthymic temperament; IT: Irritable temperament; AT: Anxious temperament; BT: BAASIS total score; TK: 
BAASIS taking dimension; TM: BAASIS timing dimension. Correlation coefficients (r) < 0.3 indicate weak correlation, ≤ 0.7 moderate correlation, > 0.7, strong 
correlation.
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associations between predictor variables (sex and years 
since transplant procedure, cyclothymic temperament, 
and anxious temperament) and outcome variable (BAA 
SIS total score), whereas no consistent associations 
between other predictor variables (age, irritable tem­
perament, IT) and outcome variable (BAASIS total score) 
were detected (Tables 2 and 3). 
dIScuSSIon
Similar studies on the subject have revealed significant 
psychological and behavioral differences between adherent 
and non­adherent transplanted patients, differences that 
express a greater vulnerability of the latter and which 
lead to consider that, next to drug therapy, psychological 
therapy is required[5,31]. Still not considered in other 
studies on the transplant topic is the temperament. “Te­
mperament has been contemporarily defined as a biolo-
gically determined, hereditary core of the personality, 
being stable and relatively unchangeable throughout life, 
which determines the basic level of reactivity, mood and 
energy of given individual”[24]. 
Based on these assumptions, this study has allowed 
us to analyze different temperament styles and suggested 
that different temperaments can influence in different 
ways the treatment compliance and quality of life of 
transplant recipients.
In this study, the biopsychosocial illness model (BIM) 
provided a conceptual frame of reference within which 
biological, psychological, and social aspects took on 
the same importance in explaining the adherence to 
treatment protocols[32]. For good treatment management, 
it is necessary to understand the patients’ personal 
experiences, their beliefs about the disease, health status 
perception, and mood, and to identify any “barriers” 
that could make them noncompliant. The analysis of 
the variables that are responsible for the behavior of 
not adhering to the treatment regimen should provide 
suggestions for psychological support and psychiatric 
treatment. Treatment adherence towards the prescribed 
medication is critical for the safe and successful delivery 
of efficacious interventions, especially for complex tasks 
such as the management of transplant patients[33,34].
The study revealed that years of transplantation 
positively affected mental health, but on the other hand, 
adversely affected therapeutic adherence, while the level 
of education was positively correlated with good mental 
balance. Studies examining the non­pharmacological risk 
factors that influence therapeutic adherence thus need 
further confirmation[5,35]. Another finding that requires 
careful reflection concerns the long-term negative impact 
that the cyclothymic and anxious personalities could 
have on adherent behavior, while the presence of post­
transplant psychological symptoms (mental health index) 
did not affect treatment adherence[36­39]. This finding 
could be related to the notion that while people with 
mental problems feel the need to be cared for and are 
more willing to properly follow the treatment protocol, 
patients with mood swings (cyclothymic temperament) 
and those in an alert and apprehensive state (anxious 
temperament) are not prepared to calmly accept the 
rigorous therapeutic protocol and require constant 
attention by healthcare staff[40]. Thus, the quality of care 
is not just about the correct prescription but also about 
the patients’ active participation through an assessment 
of their expectations and preferences. Patients adopt 
adherent behavior when they accept the type of care in 
terms of the therapeutic project[41]. Helpful in this regard 
is cognitive behavioral therapy aimed at increasing 
transplant recipients’ awareness[42].
Immediately after transplant, patients must be 
assisted to increase the capacity for self­efficacy and 
resilience necessary to achieve the correct lifestyle for 
maintaining the graft. In a next step, it would be desirable 
to establish a cognitive and psychosocial rehabilitation 
plan to improve coping strategies and strengthen the 
patients’ resources in order to positively influence the 
final outcome of the transplant process. These efforts 
therefore must operate simultaneously at several levels 
on the basis of an integrated strategy that organizes and 
coordinates the various types of treatment­medication, 
psychotherapy, assistance­and the operators’ different 
functions, in an intervention program formulated on the 
basis of the characteristics and needs of each individual 
patient[43,44]. 
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Table 2  Linear model of predictors sex, age, and years since 
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B SE B (SE) b P
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Table 3  Linear model of temperament predictors on basel 
assessment of adherence to immunosuppressive medication 
instrument total score
B SE B (SE) b P
Constant 0.87 (-0.14 to 1.88) 0.39 0.00 0.06
CT 0.51 (0.10 to 0.93) 0.16 1.92 0.02
IT -0.17 (-0.58 to 0.23) 0.16 -0.48 0.32
AT -0.28 (-0.46 to -0.09) 0.07 -1.44 0.01
CT: Cyclothymic temperament; IT: Irritable temperament; AT: Anxious 
temperament; Linear model with 95% bias corrected and accelerated 
confidence intervals (in parentheses).
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providing the BAASIS questionnaire used in this research.
coMMEntS
Background 
Adherence to immunosuppressive therapy after transplantation is of 
fundamental importance for the patients’ well-being both short- and long-term 
and assumes a set of adaptations to a new lifestyle. I pazienti trapiantati devono 
assumere quotidianamente farmaci immunosoppressori per la prevenzione 
del rigetto acuto e cronico (infezioni, complicanze secondarie). The treatment 
effectiveness and transplant success not only depend on the correct choice of 
immunosuppressive drugs, but also on the patients’ active participation in the 
therapeutic program that often includes psychological support and appropriate 
motivation. Adequate adherence to doctor’s orders is a resource for both 
patients and the health care system and society, as it reduces the costs for 
therapies, for minor complications associated with the disease, the health care 
interventions, morbidity and mortality. However various social, cultural, financial 
and psychological aspects affect adherence to immunosuppressive therapy. 
Research frontiers 
Although most research has focused on adherence to drug treatment, the 
concept of adherence must include other behaviors related to health protection 
involving the doctor-patient relationship, the service delivery system and 
change their living habits. The communication characteristics of the doctor, the 
kind of language used and the setting are essential to strengthen the motivation 
and awareness of the need for a cure. Future programs should provide the 
ability to support the transplanted in transplant experience, helping him to 
properly follow treatment, help him to learn cognitive and behavioral strategies 
of self-regulation. 
Innovations and breakthroughs
Studies of the Italian population have revealed significant differences in 
psychological and personality traits among transplant patients adherent and 
non-adherent to therapy, differences that express a greater vulnerability of the 
latter and which lead to consider that, next to drug therapy, you are required 
psychological therapy. This study also allows to analyze different temperament 
styles, yet not studied in other research on transplantation and suggests that 
different temperaments influence in different ways the treatment compliance.
Applications 
The data in this study suggested that psychological and psycho-educational 
support to the transplanted patient could yield favorable outcomes about 
adherence to immunosuppressive therapy. Furthermore, this study also 
provided readers with important informations about psychological problems that 
could highlight on transplanted subject. 
Terminology
TA is the patient’s ability to be able to follow precisely the prescribed cure. 
Specifically, the concept of adherence to therapy includes the compliance 
and persistence: Compliance reflects the acceptance of the patient to medical 
prescription (number of daily dose), the persistence instead indicates the time period 
between the start and the interruption of the treatment. BIM provided a conceptual 
frame of reference within which biological, psychological, and social aspects took on 
the same importance in explaining the adherence to treatment protocols. You must 
operate simultaneously at several levels in an intervention program formulated on 
the basis of the characteristics and needs of each individual patient. 
Peer-review 
Studies concerning the influence of temperament to the therapeutic adherence 
are scarce. The authors in this study analyzed the psychological characteristics 
of a sample of transplant recipients followed as outpatients at a transplant 
center. The results showed that the transplant experience change behaviors 
and quality of life based on the personality and temperament characteristics. 
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